import into the cell nucleus, was discovered to be post-translationally modified by a novel protein [3] . This protein turned out to be related to ubiquitin and was named "SUMO," which is short for Small Ubiquitin-like Modifier. SUMO attachment to proteins is often referred to as "sumoylation." Sumoylation of RanGAP1 localizes RanGAP1 to the cytoplasmic side of nuclear pore complex [4, 5] .
Since its discovery on RanGAP1, SUMO has been found to modify a surprisingly large number of proteins in many different organisms. Although the exact role of sumoylation for many specific proteins remains unclear, misregulation of the SUMO system is likely to contribute to tumorigenesis and autoimmune defects as well as other human diseases. The list of in vivo targets for SUMO in mammalian cells includes the tumor suppressor p53 and promyelocytic leukemia protein, or PML; the PML gene is involved in chromosomal translocations that are responsible for certain leukemias [6, 7] . Another SUMO target is Sp100, an autoantigen in primary biliary cirrhosis [7] . IκBα, a protein inhibitor of the NF-κB transcription factor, is modified by both SUMO and ubiquitin [8] . SUMO has also been shown to modify a number of transcription factors including p300 and Sp3 [9, 10] .
The biochemical affect of sumoylation on a substrate protein often remains elusive. For example, only a small pool of the transcription factor Sp3 is sumoylated at any given time. However, this minor population of modified Sp3 leads to an overall repression of the transcriptional activity of Sp3. If sumoylation of Sp3 is abolished either by a mutation of the protein's acceptor lysine, or by expression of the enzyme that removes SUMO from Sp3, there is a significant increase in transcriptional activation by Sp3 [10, 11] . Since only a minority of the Sp3 protein is sumoylated, the mechanism that allows for an enhancement of overall transcriptional activation by Sp3 when the protein's sumoylation is abolished remains a mystery.
Many SUMO targets have been identified in mammalian cells, but work in simpler, more genetically tractable organisms has greatly aided our ability to determine the specific functions of protein sumoylation.
Baker's yeast, or Saccharomyces cerevisiae, is a favorite model eukaryote, and studies of the SUMO system in this yeast have furthered our understanding of this novel protein modification system. Smt3 is the SUMO protein in yeast and its conjugation to an acceptor protein occurs by a multi-step pathway, which ultimately leads to an isopeptide bond between the C-terminal carboxyl group of the mature Smt3 and the ε-amino group of a lysine side chain of the target protein. Ulp1, which also acts as a desumoylating enzyme, cleaves the ATY tail at Smt3's C-terminus to release a 98-amino acid mature protein ending in diglycine [12] . This mature Smt3 is activated for conjugation by adenylation when Uba2/Aos1, the activating enzyme (E1), attacks the carboxyl-AMP of Smt3 to form an Uba2-Smt3 thioester. Next, the activated Smt3 is transferred by E1 to the cysteine side chain of Ubc9, the conjugating enzyme (E2). From there, Smt3 is transferred to a lysine residue on the acceptor substrate. This last transfer is often facilitated by a protein ligase (E3) functioning as an adaptor [13] , and frequently occurs at an [I/V] KXE consensus site [10] . Three currently identified E3s in yeast are Siz1, Siz2, and Mms21 [14, 15] .
In yeast, sumoylation is an essential process affecting chromosome dynamics as well as many other processes in the cell. In 1995, Smt3 was isolated in yeast in an overexpression screen as a suppressor of a temperature-sensitive Mif2 mutation [16] . The Mif2 gene encodes a centromere protein that has homology to the mammalian CENP-C centromere protein. In two later studies, Ulp2, an enzyme that removes Smt3 from its protein substrates, was found to localize to chromosomes, especially to rDNA repeats [17] , and Smt3 also was found to localize to chromosomes [18] . Furthermore, a temperature-sensitive mutation in Smt3 was identified that causes a defect in chromosomal segregation [18] .
Regulation of Smt3 modification is important for cell cycle progression. Strains mutated in enzymes required in sumoylation (ubc9) and desumoylation (ulp1) show arrest at the G2/M transition. ∆siz1 ∆siz2 double mutants show a buildup at G2/M. These phenotypes may result from a failure to properly segregate chromosomes [12, 14, 19] . In addition the ulp2 null mutant is temperature sensitive and displays decreased plasmid and chromosome stability, a severe sporulation defect; and hypersensitivity to the DNA-damaging agents hydroxyurea and MMS as well as to benomyl, a microtubule depolymerizing agent [20] . These pleiotropic effects reinforce the idea that regulation of sumoylation and desumoylation affects many processes within the cell, particularly processes related to chromosome dynamics.
Although the yeast gene encoding SUMO is required for viability, as are many of the enzymes involved in its attachment to and removal from substrates, in the limited number of substrates that have been characterized the sumoylation of these substrates is not essential for viability, indicating that there are molecular targets of Smt3 whose effect of SUMO modification is still unknown. The first sumoylated proteins identified in S. cerevisiae were a subset of the septins, which are proteins required for normal bud growth and cytokinesis. However, in the absence of sumoylation of the septins, there is no apparent phenotype in the cells [14] . A short list of proteins whose sumoylation has been characterized in yeast includes topoisomerase II (TopII). Although the sumoylation of TopII is not required for its essential function, eliminating the sumoylation results in a change of cohesive properties of the centromere [21] . Proliferating cell nuclear antigen (PCNA) is a sliding clamp for DNA-polymerase involved in DNA synthesis and repair. Sumoylation of PCNA occurs on a lysine residue, which is also ubiquitinated; this ubiquitination stimulates the repair function of PCNA [22] . The sumoylation of PCNA, which occurs predominately in S phase, has been shown to create a binding surface which interacts with Srs2 at higher levels than non-sumoylated PCNA. This Srs2-SUMO-PCNA interaction seems to decrease interchromosomal recombination rates presumably through a decrease in recombination of replicating chromosomes [23] . Sumoylation of another subset of additional proteins, which are either involved in chromosome cohesion; Pds5 and Ysc4 [24, 25] , or DNA repair proteins Yku70 and Smc5 [15] have been reported, but the sites of sumoylation are not yet mapped.
In order to better understand the importance of the SUMO pathway, a comprehensive list of sumoylated proteins must first be generated. There has been a recent flurry of proteomic experiments undertaken to address this question. Since 2004, a number of studies have added to the list of sumoylated proteins in S. cerevisiae by identifying Smt3 conjugated proteins through affinity purification of SUMO-containing proteins. This was followed by tandem mass spectrometric identification of digested peptides from the purified mixture. The constraints of these purifications were slightly different in a number of the screens. Many of the purifications were done in wild-type yeast under normal conditions [26] [27] [28] . However some purifications of SUMO-containing peptides were done under stress conditions, which increased the number of Smt3 conjugates [29] , and another purification was conducted from a ulp1 deletion strain. Ulp1 is one of the two desumoylating enzymes and this deletion also results in a higher level of sumoylated proteins [30] . Incorporating the data from these five purifications results in greater than 100 total identified proteins. However the overlap between SUMO conjugated proteins found in the various purifications in general was less than 50 percent. This suggests that separate purifications were identifying specific subsets of proteins and also that there is a high likelihood that some of the identified SUMO-interacting proteins are not true substrates of Smt3, but possible contaminating proteins. Now that a comprehensive list of sumoylated proteins in S. cerevisiae is being compiled, the next challenge is understanding the importance of sumoylation on these specific substrates.
Sumoylation has been shown to be involved in cell cycle regulation, DNA repair, and chromosomal maintenance. The yeast model has been beneficial in studying the role of sumoylation in these cellular processes, however SUMO is also implicated to play a role in a number of diseases that are only found in higher eukaryotes. These include diabetes, promyelocytic leukemias, and neurodegenerative diseases to name a few. The precise role of SUMO in these diseases is, for the most part, unclear. As an example of the type of research being done on SUMO the following is a summary of recent evidence that sumoylation contributes to Huntington's disease. Huntington's disease is characterized by the accumulation of a pathogenic protein, Huntingtin (Htt). Using a Drosophila model system, a fragment of the Htt protein was found to be modified by both SUMO and ubiquitin. When a mutant Htt was expressed throughout the fly, the level of neurodegeneration was found to be far more severe in flies with wild-type levels of SUMO as opposed to those flies, which had lowered sumoylation activity. In contrast, lowering the levels of ubiquitination activity aggravates the disease [31] . This is just one of the many examples of SUMO's role in disease. Sumoylation has been shown to affect a wide range of biological processes from yeast to humans.
Future studies on the regulation of SUMO modification as well as the physiological affect of its modification on various substrate proteins will certainly continue to make this an exciting and diverse field.
